17-82394471-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000329197.9(OGFOD3):āc.896G>Cā(p.Gly299Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,614,068 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G299R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000329197.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OGFOD3 | NM_024648.3 | c.824-1937G>C | intron_variant | ENST00000313056.10 | NP_078924.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OGFOD3 | ENST00000313056.10 | c.824-1937G>C | intron_variant | 2 | NM_024648.3 | ENSP00000320116 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152218Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251312Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135822
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1461732Hom.: 0 Cov.: 32 AF XY: 0.0000151 AC XY: 11AN XY: 727162
GnomAD4 genome AF: 0.000177 AC: 27AN: 152336Hom.: 0 Cov.: 32 AF XY: 0.000228 AC XY: 17AN XY: 74482
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.896G>C (p.G299A) alteration is located in exon 9 (coding exon 9) of the OGFOD3 gene. This alteration results from a G to C substitution at nucleotide position 896, causing the glycine (G) at amino acid position 299 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at